Live Breaking News & Updates on Olema Pharmaceuticals Stock Down

Stay updated with breaking news from Olema pharmaceuticals stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 8%

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 8%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cyrus Harmon , Group Plc , Securities Exchange Commission , Perceptive Advisors , Hedge Funds Weigh In On Olema Pharmaceuticals , News Ratings For Olema Pharmaceuticals Daily , Vanguard Group Inc , Olema Pharmaceuticals Company Profile , Insider Transactions At Olema Pharmaceuticals , Barclays Plc , Olema Pharmaceuticals Inc , Olema Pharmaceuticals Stock Down , Olema Pharmaceuticals , Get Free Report , One Financial , Pharmaceuticals Stock Down , Director Cyrus Harmon , Exchange Commission , General Group Plc , Olema Pharmaceuticals Daily ,

Analysts Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Price Target at $21.00

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned an average recommendation of “Buy” from the seven research firms that are currently covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in the last […] ....

Sean Bohen , Cyrus Harmon , Olema Pharmaceuticals Stock Down , Virtu Financial , News Ratings For Olema Pharmaceuticals Daily , Royal Bank , Citigroup Inc , Olema Pharmaceuticals Inc , Hedge Funds Weigh In On Olema Pharmaceuticals , Analyst Recommendations For Olema Pharmaceuticals , Olema Pharmaceuticals , Balyasny Asset Management , Securities Exchange Commission , Get Free Report , Pharmaceuticals Stock Down , Exchange Commission , Director Cyrus Harmon , Street Group , Asset Management , Get Free , Olema Pharmaceuticals Daily , Nasdaq Olma ,

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives $21.20 Average Target Price from Brokerages

Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) have been assigned a consensus rating of “Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have updated their coverage on […] ....

Cyrus Harmon , Sean Bohen , Olema Pharmaceuticals Inc , Royal Bank , Securities Exchange Commission , Virtu Financial , News Ratings For Olema Pharmaceuticals Daily , Analyst Recommendations For Olema Pharmaceuticals , Jpmorgan Chase Co , Balyasny Asset Management , Citigroup Inc , Olema Pharmaceuticals , Olema Pharmaceuticals Stock Down , Get Free Report , Exchange Commission , Director Cyrus Harmon , Street Group , Asset Management , Pharmaceuticals Stock Down , Get Free , Olema Pharmaceuticals Daily , Nasdaq Olma ,

Olema Pharmaceuticals (NASDAQ:OLMA) Trading 3.4% Higher

Olema Pharmaceuticals (NASDAQ:OLMA) Trading 3.4% Higher
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cyrus Harmon , Securities Exchange Commission , Olema Pharmaceuticals Inc , Olema Pharmaceuticals Company Profile , News Ratings For Olema Pharmaceuticals Daily , Jpmorgan Chase Co , Olema Pharmaceuticals , Royal Bank , Balyasny Asset Management , Institutional Trading Of Olema Pharmaceuticals , Citigroup Inc , Virtu Financial , Olema Pharmaceuticals Stock Down , Get Free Report , Pharmaceuticals Stock Down , Director Cyrus Harmon , Exchange Commission , Biocapital Advisors , Street Group , Asset Management , Olema Pharmaceuticals Daily ,